ResearcherSun Yat-sen UniversityActive in the last 2 years
Yanyan Zhuang
Matched on ORCID iD 0000-0001-5356-9370; OpenAlex author ID A5023939244, A5137624957. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 14
- Serial PNA-Transformer-Based Virtual Screening Identifies Nanomolar DYRK1A Inhibitors for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1021/acsmedchemlett.5c00723↗
- Erratum to "tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2" [GENE 927C (2024) 148739]. Co-author DOI 10.1016/j.gene.2024.148909↗
- tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2. Co-author DOI 10.1016/j.gene.2024.148739↗
- Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41417-024-00786-4↗
- Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment. Co-author DOI 10.3390/cancers15020474↗
- Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Co-author DOI 10.1186/s12943-022-01678-7↗
- METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fcell.2022.759020↗
- SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jgm.3364↗
- CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41420-021-00759-8↗
- LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Co-author DOI 10.1186/s12943-018-0845-6↗
- MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Co-author DOI 10.1007/s10620-017-4472-7↗
- MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. Co-author DOI 10.1371/journal.pone.0087897↗
- Silencing of GATA6 suppresses SW1990 pancreatic cancer cell growth in vitro and up-regulates reactive oxygen species. Co-author DOI 10.1007/s10620-013-2752-4↗
- Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance. Co-author DOI 10.3892/ijo.2012.1597↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shineng Zhang · 13 shared papers, 2012–2025 · strength 1.85
- Paper Erratum to "tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targ… DOI 10.1016/j.gene.2024.148909↗
- Paper Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pan… DOI 10.1038/s41417-024-00786-4↗
- Paper tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2. DOI 10.1016/j.gene.2024.148739↗
- Juanfei Peng · 8 shared papers, 2017–2024 · strength 1.21
- Paper Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pan… DOI 10.1038/s41417-024-00786-4↗
- Paper Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment. DOI 10.3390/cancers15020474↗
- Paper METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. DOI 10.3389/fcell.2022.759020↗
- Fengting Huang · 10 shared papers, 2012–2023 · strength 1.07
- Paper Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment. DOI 10.3390/cancers15020474↗
- Paper METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. DOI 10.3389/fcell.2022.759020↗
- Paper Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma develo… DOI 10.1186/s12943-022-01678-7↗
- Sihua Lan · 4 shared papers, 2022–2025 · strength 0.91
- Paper Erratum to "tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targ… DOI 10.1016/j.gene.2024.148909↗
- Paper tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2. DOI 10.1016/j.gene.2024.148739↗
- Paper Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment. DOI 10.3390/cancers15020474↗
- Dandan Zheng · 3 shared papers, 2021–2025 · strength 0.68
- Paper Erratum to "tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targ… DOI 10.1016/j.gene.2024.148909↗
- Paper Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of m6A-modified PTEN mRNA in pan… DOI 10.1038/s41417-024-00786-4↗
- Paper CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreati… DOI 10.1038/s41420-021-00759-8↗
- Wen‐Ying Chen · 4 shared papers, 2017–2022 · strength 0.42
- Paper Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma develo… DOI 10.1186/s12943-022-01678-7↗
- Paper SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma. DOI 10.1002/jgm.3364↗
- Paper LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20… DOI 10.1186/s12943-018-0845-6↗
- Hongyu Zhang · 1 shared paper, 2026 · strength 0.33
- Liting Lu · 2 shared papers, 2021–2022 · strength 0.29
- Wa Zhong · 1 shared paper, 2023 · strength 0.22
- Wenbo Chen · 3 shared papers, 2012–2014 · strength 0.12
- Paper MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. DOI 10.1371/journal.pone.0087897↗
- Paper Silencing of GATA6 suppresses SW1990 pancreatic cancer cell growth in vitro and up-regulates reactive oxygen species. DOI 10.1007/s10620-013-2752-4↗
- Paper Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance. DOI 10.3892/ijo.2012.1597↗
- Yongxun Zhuansun · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.